OBJECTIVES: Little epidemiologic research has examined the practice of electroconvulsive therapy (ECT). We investigated sociodemographic and clinical characteristics, service use, and psychotropic medication prescription patterns associated with ECT use at a Veterans Health Administration Medical Center. METHODS: Among veterans receiving specialty mental health services, we compared those who received ECT with those who did not using bivariate χ and t tests and multivariate logistic regression. RESULTS: In fiscal year 2012, 11,117 veterans received specialty mental health services, of whom 50 received ECT (0.45%) in FY2012 or FY2013. Those who received ECT were more likely to be diagnosed with major depressive or bipolar disorders and had substantially higher levels of mental health service usage (Cohen d > 0.75) and psychotropic prescription fills, including antidepressants (Cohen d = 2.66), antipsychotics (Cohen d = 2.15), lithium (Cohen d = 1.34), mood stabilizers (Cohen d = 1.30), and anxiolytic/sedative/hypnotics (Cohen d = 1.34). CONCLUSIONS: Our findings suggest that ECT is used as a treatment of last resort, although available evidence and guidelines recommend wider use.
OBJECTIVES: Little epidemiologic research has examined the practice of electroconvulsive therapy (ECT). We investigated sociodemographic and clinical characteristics, service use, and psychotropic medication prescription patterns associated with ECT use at a Veterans Health Administration Medical Center. METHODS: Among veterans receiving specialty mental health services, we compared those who received ECT with those who did not using bivariate χ and t tests and multivariate logistic regression. RESULTS: In fiscal year 2012, 11,117 veterans received specialty mental health services, of whom 50 received ECT (0.45%) in FY2012 or FY2013. Those who received ECT were more likely to be diagnosed with major depressive or bipolar disorders and had substantially higher levels of mental health service usage (Cohen d > 0.75) and psychotropic prescription fills, including antidepressants (Cohen d = 2.66), antipsychotics (Cohen d = 2.15), lithium (Cohen d = 1.34), mood stabilizers (Cohen d = 1.30), and anxiolytic/sedative/hypnotics (Cohen d = 1.34). CONCLUSIONS: Our findings suggest that ECT is used as a treatment of last resort, although available evidence and guidelines recommend wider use.
Authors: Leonardo F Fontenelle; Evandro S F Coutinho; Natália M Lins-Martins; Paul B Fitzgerald; Hironobo Fujiwara; Murat Yücel Journal: J Clin Psychiatry Date: 2015-07 Impact factor: 4.384
Authors: Brady G Case; David N Bertollo; Eugene M Laska; Lawrence H Price; Carole E Siegel; Mark Olfson; Steven C Marcus Journal: Biol Psychiatry Date: 2012-10-08 Impact factor: 13.382
Authors: Harold A Sackeim; Joan Prudic; Mitchell S Nobler; Linda Fitzsimons; Sarah H Lisanby; Nancy Payne; Robert M Berman; Eva-Lotta Brakemeier; Tarique Perera; D P Devanand Journal: Brain Stimul Date: 2008-04 Impact factor: 8.955
Authors: Helle K Schoeyen; Ute Kessler; Ole A Andreassen; Bjoern H Auestad; Per Bergsholm; Ulrik F Malt; Gunnar Morken; Ketil J Oedegaard; Arne Vaaler Journal: Am J Psychiatry Date: 2014-10-31 Impact factor: 18.112
Authors: Zhi-Min Wang; Hui Zhu; Yan-Li Pan; Helen F K Chiu; Christoph U Correll; Gabor S Ungvari; Kelly Y C Lai; Xiao-Lan Cao; Yan Li; Bao-Liang Zhong; Xiang-Yang Zhang; Yu-Tao Xiang Journal: J ECT Date: 2015-06 Impact factor: 3.635
Authors: Pia Nordanskog; Martin Hultén; Mikael Landén; Johan Lundberg; Lars von Knorring; Axel Nordenskjöld Journal: J ECT Date: 2015-12 Impact factor: 3.635
Authors: Tyler S Kaster; Daniel M Blumberger; Tara Gomes; Rinku Sutradhar; Zafiris J Dasklakis; Duminda N Wijeysundera; Simone N Vigod Journal: Can J Psychiatry Date: 2020-07-02 Impact factor: 4.356